Lennar Q3 Earnings & Revenues Beat, Stock Down on Tepid Q4 View
ZACKS· 2024-09-21 00:51
Lennar Corporation (LEN) reported third-quarter fiscal 2024 results, wherein its earnings and revenues surpassed the Zacks Consensus Estimate.On a year-over-year basis, revenues increased, given the company’s emphasis on maintaining a steady production rate to drive sales momentum. Lennar strategically utilized pricing, incentives, marketing expenditure and dynamic pricing insights to ensure steady sales volume despite fluctuations in interest rates.However, earnings fell by a cent from the year-ago period. ...
SNN Stock Rises on the Completion of First Case With CATALYSTEM System
ZACKS· 2024-09-21 00:51
Smith & Nephew SNATS (SNN) recently announced the completion of the first surgery case using its latest CATALYSTEM Primary Hip System. The first surgical procedure using the CATALYSTEM System was completed in the second week of September by three prominent orthopedic surgeons — Dr. Thorsten Seyler of Duke University, Dr. George Haidukewych of Orlando Health, and Dr. Ran Schwarzkopf of NYU Langone Health.The CATALYSTEM Primary Hip System makes use of the exclusive, patent-pending ACCUBROACH Technology, which ...
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Sage Therapeutics, Inc. (SAGE)
GlobeNewswire News Room· 2024-09-21 00:49
LOS ANGELES, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming October 28, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Sage Therapeutics, Inc. (“Sage” or the “Company”) (NASDAQ: SAGE) securities between April 12, 2021 and July 23, 2024, inclusive (the “Class Period”). If you suffered a loss on your Sage investments or would like to inquire about potentially pursuing c ...
ESRT vs. NHI: Which Stock Is the Better Value Option?
ZACKS· 2024-09-21 00:46
Investors interested in REIT and Equity Trust - Other stocks are likely familiar with Empire State Realty Trust (ESRT) and National Health Investors (NHI) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The Zacks Rank is a proven s ...
MAN vs. RHI: Which Stock Is the Better Value Option?
ZACKS· 2024-09-21 00:46
Investors looking for stocks in the Staffing Firms sector might want to consider either ManpowerGroup (MAN) or Robert Half (RHI) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The proven Zacks Rank emphasizes companies ...
Weave Communications (WEAV) Surges 8.1%: Is This an Indication of Further Gains?
ZACKS· 2024-09-21 00:46
Weave Communications, Inc. (WEAV) shares ended the last trading session 8.1% higher at $12.02. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 1.2% gain over the past four weeks.Weave is benefiting from the growing adoption of its solution, which is driving average revenue per user. Expanding footprint in the dental, optometry, veterinary and specialty medical markets has been a positive.This company is expected to ...
Bel Fuse (BELFB) Soars 16.5%: Is Further Upside Left in the Stock?
ZACKS· 2024-09-21 00:46
Bel Fuse (BELFB) shares ended the last trading session 16.5% higher at $80.93. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 5.9% gain over the past four weeks.Belfuse is benefiting from an expanding product portfolio, increasing end-customer demand and a favorable product mix.This maker of electronic products for circuits is expected to post quarterly earnings of $0.85 per share in its upcoming report, which rep ...
V.F. Corp Stock Gains 30% in 3 Months: What's Next for Investors?
ZACKS· 2024-09-21 00:46
V.F. Corporation (VFC) has provided investors with solid gains, appreciating 31.7% over the past three months. This performance outpaces the industry’s decline of 3.5% and the S&P 500’s 4.4% growth. This gain is attributed to several factors, including its Reinvent transformation program, cost-reduction initiatives and strengthening balance sheet.One of the most crucial aspects of V.F. Corp's recent progress is its focus on stabilizing gross margins. While the company continues to face near-term uncertainti ...
Fortive To Separate Into Two Public Companies
Forbes· 2024-09-21 00:45
(Photo Illustration by Igor Golovniov/SOPA Images/LightRocket via Getty Images)LightRocket via Getty ImagesDeal OverviewOn September 04, 2024, Fortive Corporation (NYSE: FTV, $75.71; Market Cap: $26.52 billion) announced its plans to spin-off its Precision Technologies segment (“NewCo”). The spin-off will result in the formation of two separate publicly traded companies, each with distinct business models and customized investment and capital allocation strategies.Post separation, Fortive (stub) will includ ...
Ideaya Biosciences Advances Synthetic Lethality With IDE397 Success
Seeking Alpha· 2024-09-21 00:45
IDEAYA Biosciences, Inc. (NASDAQ: IDYA ) is a unique precision oncology company. IDYA leverages its synthetic lethality platform to exploit genetic vulnerabilities in cancer cells. The company mainly focuses on MTAP-deleted tumors and BRCA/HRD mutations. Its pipeline includes candidates such as Darovasertib, currentlyMy name is Myriam Hernandez Alvarez. I received the Electronics and Telecommunication Engineering degree from the Escuela Politecnica Nacional, Quito, Ecuador, the M.Sc. degree in computer scie ...